Study Highlights Image-Guided Superficial Radiation Therapy as a Viable First-Line Treatment for Nonmelanoma Skin Cancer
Source: Dermatology Times, February 2025
Study author Erin McClure, MD, discusses how IGSRT offers consistent NMSC recurrence rates across socioeconomic and comorbidity factors, reinforcing its role as a first-line treatment.
The Dermatology Association of Radiation Therapy (DART) recently announced the publication of the first large retrospective cohort study evaluating the impact of neighborhood-level socioeconomic deprivation and patient-level comorbidities on freedom from recurrence following image-guided superficial radiation therapy (IGSRT) for nonmelanoma skin cancer (NMSC).
The study, published in Cancers,2 found that these factors did not significantly impact recurrence rates, reinforcing IGSRT as a viable treatment option for patients who cannot or choose not to undergo surgery.